dichloroacetic acid has been researched along with Ovarian Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dvořák, Z; Štarha, P; Trávníček, Z; Vančo, J | 1 |
| Goto, S; Kamigaki, T; Saito, M; Yano, K | 1 |
| He, F; He, J; Huang, Y; Li, B; Li, X; Lyu, X; Ni, Z; Wang, Y; Wu, Y; Yan, X; Zeng, Y; Zhang, Y; Zheng, Y | 1 |
| Abu-Soud, HM; Diamond, MP; Fletcher, NM; Jiang, ZL; Saed, GM | 1 |
4 other study(ies) available for dichloroacetic acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand.
Topics: Cell Proliferation; Coordination Complexes; Dichloroacetic Acid; Drug Liberation; Female; Humans; Ligands; Osmium; Ovarian Neoplasms; Phenanthrolines; Ruthenium | 2018 |
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium | 2013 |
Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Dichloroacetic Acid; Drug Synergism; Drug Therapy, Combination; Female; Growth Inhibitors; Humans; Lactic Acid; Metformin; Mice; Mice, Nude; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Dichloroacetate induces apoptosis of epithelial ovarian cancer cells through a mechanism involving modulation of oxidative stress.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Dichloroacetic Acid; Dose-Response Relationship, Drug; Epithelial Cells; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoprecipitation; In Situ Nick-End Labeling; Nitric Oxide Synthase Type II; Ovarian Neoplasms; Oxidation-Reduction; Oxidative Stress; Peroxidase; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase | 2011 |